ESMO 2026 has ended. This guide stays up as the record of who was there. Next: ESMO 2027, Sep 17–21, 2027 in Barcelona
Champalimaud Foundation at ESMO 2026
Oct 23–27, 2026 Madrid, Spain ~37k attendees Website
Champalimaud Foundation takes part in 3 sessions at ESMO 2026 in Madrid. Its work centres on breast cancer prevention and reducing treatment intensity. It examines pertuzumab use in early breast cancer with no lymph-node involvement.
| Organization | ESMO 2026 Attendance |
|---|---|
Champalimaud Foundation Lisbon, Portugal | |
Private biomedical research foundation in Lisbon, Portugal, whose clinical centre treats cancer patients. | Poster Fri Oct 23 13:00–15:00 Talk Sun Oct 25 17:20–17:45 Breast cancer drug prevention in 2026 Breast cancer Chair Mon Oct 26 10:15–11:45 Rapid oral 2: Basic science and translational research Biomarkers & precision oncology Abstract Mon Oct 26 10:30–10:42 Invited Discussant 4249RO, 4250RO and 4251RO Biomarkers & precision oncology |
Find decision makers at Champalimaud Foundation
Tell us what you sell and we’ll find the people at Champalimaud Foundation most likely to buy it.
- Who to contact
- Their contact info
- What to say
- Free, no sign-up
Not affiliated with or endorsed by the European Society for Medical Oncology. Submit a correction